Stock listing

Turquoise:AZNS AstraZeneca PLC Share Price

UK listing (Turquoise) of AstraZeneca PLC · home listing LSE:AZN

Follow AstraZeneca PLC into a list and get an email when it puts out news.

Home listing price · LSE:AZN

13,412p GBX (pence) -234 (-1.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:AZN

Past year -1.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
13,350p – 13,538p GBX (pence)Nov 20, 2026
Volume
2.18M sharesNov 20, 2026
Market cap
£208.0B GBPAt the close on Nov 20, 2026 · price × 1.55B shares outstanding
52-week range
9,892.00p – 15,732p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£342.8M GBPMedian day 2.26M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
AstraZeneca PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:AZN · Home13,412p GBX (pence)-234 (-1.7%)2,180,34313,432p13,538p13,350p13,646pClose on Nov 20, 2026
NYSE:AZN$174.35 USD-1.06 (-0.6%)2,022,735$176.14$177.47$174.04$175.41Close on Nov 20, 2026
Stockholm:AZN1,796.00 SEK+18.50 (+1.0%)462,5541,790.001,812.001,784.501,777.50Close on Nov 20, 2026
Frankfurt:ZEG€159.55 EUR-2.15 (-1.3%)—€159.60€161.50€159.20€161.70Close on Nov 20, 2026
B3:A1ZN34174.09 BRL-1.91 (-1.1%)179173.57174.09172.28176.00Close on Nov 19, 2026
Stuttgart:ZEG€158.95 EUR-0.75 (-0.5%)56€158.35€161.05€158.35€159.70Close on Nov 20, 2026
Munich:ZEG€158.35 EUR-0.95 (-0.6%)—€158.90€158.90€158.35€159.30Close on Nov 20, 2026
Hamburg:ZEG€160.10 EUR+1.60 (+1.0%)—€158.45€160.10€158.40€158.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:AZN · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
13,412p-234-1.7%13,432p13,538p13,350p2,180,343
13,646p-156-1.1%13,770p13,850p13,578p1,591,835
13,802p-232-1.7%13,938p13,956p13,722p1,619,308
14,034p+52+0.4%14,056p14,222p13,964p2,286,583
13,982p+52+0.4%13,902p14,064p13,892p1,059,168
13,930p+34+0.2%14,024p14,080p13,890p2,096,019
13,896p+12+0.1%13,902p13,962p13,824p1,328,928
13,884p-182-1.3%14,114p14,148p13,884p3,288,630
14,066p+136+1.0%13,920p14,184p13,918p1,520,835
13,930p-112-0.8%13,696p13,950p13,458p2,588,516
14,042p+18+0.1%14,228p14,312p13,966p5,685,723
14,024p+264+1.9%13,768p14,062p13,582p3,691,327
13,760p-100-0.7%13,964p13,984p13,760p2,262,803
13,860p-100-0.7%13,704p13,932p13,678p2,535,557
13,960p+908+7.0%13,438p14,002p13,308p4,546,444
13,052p+288+2.3%12,808p13,166p12,782p1,401,291
12,764p-58-0.5%12,756p12,932p12,642p1,158,441
12,822p-32-0.2%12,848p12,912p12,724p2,178,329
12,854p+30+0.2%12,882p12,976p12,806p1,603,348
12,824p-156-1.2%12,906p12,906p12,672p2,108,440
12,980p+366+2.9%12,602p12,980p12,520p1,798,652
12,614p-40.0%12,602p12,692p12,536p1,768,801
12,618p+218+1.8%12,440p12,626p12,386p4,422,284
12,400p-46-0.4%12,440p12,470p12,298p2,088,289
12,446p-252-2.0%12,506p12,576p12,418p2,901,078
12,698p+398+3.2%12,396p12,806p12,334p5,442,067
12,300p+404+3.4%11,820p12,330p11,816p2,182,102
11,896p-130-1.1%12,170p12,310p11,882p2,152,484
12,026p+28+0.2%12,038p12,078p11,916p1,751,377
11,998p+106+0.9%12,024p12,112p11,982p4,458,670
11,892p-288-2.4%12,032p12,124p11,890p2,276,972
12,180p+222+1.9%11,912p12,180p11,894p1,721,628
11,958p+194+1.6%11,904p12,112p11,782p2,189,050
11,764p-106-0.9%11,900p11,972p11,716p1,619,066
11,870p-162-1.3%11,800p12,094p11,790p1,659,275
12,032p-248-2.0%12,014p12,281p12,010p3,717,062
12,280p-148-1.2%12,436p12,518p12,250p3,855,859
12,428p-64-0.5%12,526p12,788p12,386p2,735,445
12,492p-60-0.5%12,614p12,632p12,446p1,550,979
12,552p+152+1.2%12,400p12,614p12,398p1,735,781
12,400p-30-0.2%12,418p12,506p12,316p2,112,194
12,430p-242-1.9%12,564p12,662p12,430p1,690,605
12,672p+112+0.9%12,606p12,690p12,478p4,821,834
12,560p+60+0.5%12,450p12,631p12,364p3,916,913
12,500p+72+0.6%12,460p12,596p12,396p6,543,165
12,428p+292+2.4%12,202p12,428p12,148p2,815,365
12,136p+20+0.2%12,098p12,296p12,074p5,327,145
12,116p-38-0.3%12,236p12,236p11,922p3,056,945
12,154p+446+3.8%11,698p12,218p11,692p6,470,194
11,708p-50-0.4%11,810p11,960p11,708p1,474,760
11,758p+108+0.9%11,634p11,802p11,552p2,070,437
11,650p-226-1.9%11,850p11,998p11,598p3,566,251
11,876p-166-1.4%11,958p12,122p11,852p2,302,552
12,042p+36+0.3%11,986p12,210p11,952p1,976,565
12,006p-140-1.2%12,146p12,210p11,984p2,248,699
12,146p+170+1.4%12,066p12,290p12,018p2,394,368
11,976p+14+0.1%12,032p12,194p11,846p2,766,204
11,962p-8-0.1%11,650p12,132p11,650p2,914,975
11,970p-144-1.2%12,200p12,200p11,958p3,627,956
12,114p-120-1.0%12,194p12,236p12,066p3,580,853
12,234p-242-1.9%12,450p12,464p12,214p2,784,068
12,476p+366+3.0%12,220p12,476p12,124p2,036,385
12,110p-130-1.1%12,182p12,204p12,016p1,791,745
12,240p+152+1.3%11,926p12,242p11,926p2,344,334
12,088p+38+0.3%12,162p12,162p11,844p3,149,124
Ticker
Turquoise:AZNS
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Turquoise
Currency
SEK

What changed lately

Latest news

All AstraZeneca PLC news

AstraZeneca PLC on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
184 in the last 12 months · 871 in all · newest Nov 16, 2026 · oldest 2016
Calls
16 calls with a replay · 16 with a transcript · latest Jul 27, 2026
Decks
333 decks · latest Oct 30, 2026

Where AstraZeneca PLC is listed

ListingExchangeCountryCurrency
LSE:AZN · Home listingLSEUnited KingdomGBX
NYSE:AZNNYSEUnited StatesUSD
Stockholm:AZNStockholmSwedenSEK
gettex:ZEGgettexGermanyEUR
BCBA:AZNBCBAArgentinaARS
Tradegate:ZEGTradegateGermanyEUR
LS Exchange:886455LS ExchangeGermanyEUR
Frankfurt:ZEGFrankfurtGermanyEUR
B3:A1ZN34B3BrazilBRL
BOATS:AZNBOATSUnited StatesUSD
Lang & Schwarz:886455Lang & SchwarzGermanyEUR
Aquis:AZNLAquisUnited KingdomGBX
BMV:AZNNBMVMexicoMXN
BMV:AZN1NBMVMexicoMXN
BCBA:AZNDBCBAArgentinaUSD
Turquoise:AZNLTurquoiseUnited KingdomGBX
Stuttgart:ZEGStuttgartGermanyEUR
Munich:ZEGMunichGermanyEUR
Aquis:AZNSAquisUnited KingdomSEK
BSESOF:ZEGBSESOFBulgariaEUR
BCBA:AZNCBCBAArgentinaUSD
BIVA:AZN1NBIVAMexicoMXN
BX Swiss:ZEGBX SwissSwitzerlandCHF
Aquis:AZNSAquisUnited KingdomSEK
Hamburg:ZEGHamburgGermanyEUR
Hanover:ZEGHanoverGermanyEUR
Lang & Schwarz:886715Lang & SchwarzGermanyEUR
Turquoise:AZNS · This pageTurquoiseUnited KingdomSEK
Dusseldorf:ZEGDusseldorfGermanyEUR
LS Exchange:886715LS ExchangeGermanyEUR
BCBA:AZN.CIBCBAArgentinaARS

Valuation

P/E 24.6× against a median of 26.7×: 6th lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
£227.8B GBP
P/E
24.6×
EV/sales
4.8×
EV/EBITDA
14.1×
Price/book
5.3×
Gross margin
77.6%
Operating margin
23.6%
Net margin
17.7%
Debt to equity
0.7×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
AstraZeneca PLC · LSE:AZNUS$272.1BUS$298.0B24.6×4.8×14.1×5.3×17.7%0.7×n/a
Johnson & Johnson · NYSE:JNJUS$651.1BUS$678.5B40.5×6.8×n/a8.0×16.2%0.6×-0.02
AbbVie Inc. · NYSE:ABBVUS$505.9BUS$503.8B48.9×7.6×n/an/a15.7%n/a0.00
Merck & Company, Inc. · NYSE:MRKUS$329.7BUS$373.8B134×5.5×n/a7.3×3.6%1.2×0.28
Novartis AG · SIX:NOVNUS$287.4BUS$304.7B20.6×n/an/a6.2×n/a0.6×n/a
Pfizer, Inc. · NYSE:PFEUS$156.2BUS$207.8B38.7×3.3×9.6×1.8×6.3%0.7×0.29
Vertex Pharmaceuticals Incorporated · NASDAQ:VRTXUS$130.6BUS$128.8B32.8×9.9×28.4×6.3×30.7%0.2×0.47
Novo Nordisk A/S Class B · OMXCOP:NOVO_BUS$129.4BUS$142.3B7.8×2.9×5.5×4.0×33.9%0.6×n/a
Bristol-Myers Squibb Company · NYSE:BMYUS$120.2BUS$151.3B13.0×3.0×n/a5.1×18.5%1.9×0.26
Sanofi SA · EURONEXT:SANUS$111.7BUS$126.9B14.6×2.3×4.7×1.4×13.9%0.3×n/a
GSK plc · LSE:GSKUS$96.63BUS$123.8B17.0×2.8×9.3×3.9×13.0%1.3×n/a
Median of the othersUS$143.4BUS$179.5B26.7×3.3×9.3×5.1×15.7%0.6×0.27

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
16329.66 GBX · Analysts' mean
EPS, year to Dec 2026
10.24 · 25 analysts
Revenue, year to Dec 2026
63.38B · 25 analysts

Team and board

Officers

OfficerRole
Marc DunoyerChief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca
Pascal SoriotExecutive Director and CEO
Aradhana SarinExecutive Director and CFO
Jeff PottChief Human Resources Officer, Chief Compliance Officer and General Counsel
David FredricksonExecutive Vice-President, Oncology Business Unit
Iskra ReicExecutive Vice-President, International
Pam ChengExecutive Vice President, Global Operations, IT & Chief Sustainability Officer
Ruud DobberExecutive Vice-President, BioPharmaceuticals Business Unit
Sharon BarrExecutive Vice-President, BioPharmaceuticals R&D
Susan GalbraithExecutive Vice-President, Oncology R&D

Board

DirectorRole
Michel DemaréNon-Executive Chair of the Board
Anna ManzNon-Executive Director
Aradhana SarinExecutive Director and CFO
Birgit ConixNon-Executive Director
Diana LayfieldNon-Executive Director
Euan AshleyNon-Executive Director
Karen KnudsenNon-Executive Director
Marcus WallenbergNon-Executive Director
Pascal SoriotExecutive Director and CEO
Sheri McCoyNon-Executive Director
Tony MokNon-Executive Director
Wan Ling MartelloNon-Executive Director

Events

Calls

CallWhenStatus
AstraZeneca (LSE:AZN) Q2 2026 Earnings CallMon, Jul 27, 2026 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q1 2026 Earnings CallWed, Apr 29, 2026 · 9:30 AM ETReplay
AstraZeneca (LSE:AZN) Q4 2025 Earnings CallTue, Feb 10, 2026 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q3 2025 Earnings CallTue, Nov 11, 2025 · 9:00 AM ETReplay
AstraZeneca (LSE:AZN) Q2 2025 Earnings CallTue, Jul 29, 2025 · 9:00 AM ETReplay
AstraZeneca (LSE:AZN) Q1 2025 Earnings CallTue, Apr 29, 2025 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q4 2024 Earnings CallThu, Feb 06, 2025 · 6:00 AM ETReplay
AstraZeneca (LSE:AZN) Q3 2024 Earnings CallTue, Nov 12, 2024 · 9:00 AM ETReplay
AstraZeneca (LSE:AZN) Q2 2024 Earnings CallThu, Jul 25, 2024 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q1 2024 Earnings CallThu, Apr 25, 2024 · 6:45 PM ETReplay
All 16 calls
CallWhenStatus
AstraZeneca (LSE:AZN) Q4 2023 Earnings CallThu, Feb 08, 2024 · 7:45 AM ETReplay
AstraZeneca (LSE:AZN) Q3 2023 Earnings CallWed, Nov 15, 2023 · 9:00 AM ETReplay
AstraZeneca (LSE:AZN) Q2 2023 Earnings CallFri, Jul 28, 2023 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q1 2023 Earnings CallThu, Apr 27, 2023 · 6:45 AM ETReplay
AstraZeneca (LSE:AZN) Q4 2022 Earnings CallThu, Feb 09, 2023 · 11:00 AM ETReplay
AstraZeneca (LSE:AZN) Q2 2022 Earnings CallFri, Jul 29, 2022 · 6:45 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 30, 2026 · After close−0.7%
Q2 2026Jul 27, 2026 · Before open+1.7%
Q1 2026Apr 29, 2026 · Before open−1.5%
Q4 2025Feb 10, 2026 · Before open+2.0%
Q3 2025Nov 6, 2025 · Before open+3.1%
Q2 2025Jul 29, 2025 · Before open+3.4%
Q1 2025Apr 29, 2025 · Before open+0.9%
Q4 2024Feb 6, 2025 · Before open+5.9%
Q3 2024Nov 12, 2024 · Before open+0.1%
Q2 2024Jul 25, 2024 · Before open−1.3%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 25, 2024 · Before open+5.9%
Q4 2023Feb 8, 2024 · Before open−6.4%
Q3 2023Nov 9, 2023 · Before open+2.6%
Q2 2023Jul 28, 2023 · Before open+3.4%
Q1 2023Apr 27, 2023 · Before open−0.4%
Q4 2022Feb 9, 2023 · Before open+4.1%
Q3 2022Nov 10, 2022 · Before open+2.9%
Q2 2022Jul 29, 2022 · Before open−0.2%
Q1 2022Apr 29, 2022 · Before open+1.2%
Quarter to Dec 31, 2021Feb 10, 2022 · Before open+3.4%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings153 slidesOct 30, 2026
9M and Q3 2026 Earnings PresentationEarnings46 slidesOct 30, 2026
ESMO 2026 Investor EventConference59 slidesOct 26, 2026
ASBMR 2026Conference33 slidesOct 12, 2026
Meet AZN Management @ ERS 2026Conference35 slidesSep 8, 2026
H1 2026 Earnings PresentationEarnings154 slidesJul 27, 2026
H1 2026 Earnings PresentationEarnings43 slidesJul 27, 2026
ESG Presentation (July 2026)Sustainability16 slidesJul 6, 2026
Investor Day (June 2026)Investor day55 slidesJun 8, 2026
ADA 2026Conference41 slidesJun 8, 2026
Show 50 decks
DeckKindSlidesDate
ASCO 2026 Investor EventConference41 slidesJun 1, 2026
Q1 2026 Earnings PresentationEarnings148 slidesApr 29, 2026
Q1 2026 Earnings PresentationEarnings40 slidesApr 29, 2026
Debt Investor Presentation (February 2026)Debt investors40 slidesFeb 10, 2026
FY 2025 Earnings PresentationEarnings163 slidesFeb 10, 2026
Q4 2025 Earnings PresentationEarnings45 slidesFeb 10, 2026
JP Morgan Healthcare Conference 2026Conference25 slidesJan 13, 2026
Q3 2025 Earnings PresentationEarnings39 slidesNov 11, 2025
Q3 2025 Earnings PresentationEarnings156 slidesNov 6, 2025
ESMO Investor Event 2025Conference53 slidesOct 20, 2025
ESC 2025Conference33 slidesAug 31, 2025
Debt Investor Presentation (July 2025)Debt investors36 slidesJul 29, 2025
H1 2025 Earnings PresentationEarnings149 slidesJul 29, 2025
Q2 2025 Earnings PresentationEarnings41 slidesJul 29, 2025
ASCO Investor Event 2025Conference49 slidesJun 2, 2025
Q1 2025 Earnings PresentationEarnings143 slidesApr 29, 2025
Q1 2025 Earnings PresentationEarnings40 slidesApr 29, 2025
Debt Investor Presentation (February 2025)Debt investors34 slidesFeb 6, 2025
FY2024 Earnings PresentationEarnings151 slidesFeb 6, 2025
FY2024 Earnings PresentationEarnings42 slidesFeb 6, 2025
JP Morgan Healthcare Conference 2025Conference26 slidesJan 14, 2025
Investor Day (November 2024)Investor day44 slidesNov 15, 2024
Q3 2024 Earnings PresentationEarnings159 slidesNov 12, 2024
Q3 2024 Earnings PresentationEarnings38 slidesNov 12, 2024
Investor Day (November 2024)Investor day40 slidesNov 4, 2024
Investor Day (September 2024)Investor day55 slidesSep 16, 2024
Investor Day (September 2024)Investor day40 slidesSep 9, 2024
Debt Investor Presentation (July 2024)Debt investors33 slidesJul 25, 2024
H1 2024 Earnings PresentationEarnings151 slidesJul 25, 2024
H1 and Q2 2024 Earnings PresentationEarnings38 slidesJul 25, 2024
Investor Day (June 2024)Investor day59 slidesJun 3, 2024
Q1 2024 Earnings PresentationEarnings147 slidesApr 25, 2024
Q1 2024 Earnings PresentationEarnings36 slidesApr 25, 2024
ESG Presentation (March 2024)Sustainability15 slidesMarch 2024
Debt Investor Presentation (February 2024)Debt investors39 slidesFeb 8, 2024
FY2023 Earnings PresentationEarnings144 slidesFeb 8, 2024
FY2023 Earnings PresentationEarnings45 slidesFeb 8, 2024
JP Morgan Healthcare Conference 2024Conference26 slidesJan 9, 2024
Investor Day (2024)Investor day32 slides2024
Investor Day (2024)Investor day56 slides2024

This page holds 50 of 333 decks. Open Decks

Open Decks

Financings

RaiseDateIn US dollars
Notes (four series)
Update: €2.55B · Barclays Bank PLC +2
Dealers: Barclays Bank PLC (co-lead), Goldman Sachs International (co-lead), Morgan Stanley (co-lead)
Use of proceeds: General corporate purposes
Sep 1, 2026US$2.98B
Fixed rate notes
Announced: US$2B · BofA Securities, Inc. +3
Dealers: BofA Securities, Inc. (co-lead), Deutsche Bank Securities Inc. (co-lead), HSBC Securities (USA) Inc. (co-lead), Mizuho Securities USA LLC (co-lead)
Use of proceeds: General corporate purposes, which may include refinancing existing indebtedness
Feb 26, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue58.7B54.1B45.8B44.4B37.4B26.6B24.4B22.1B22.5B23.0B
Cost of revenue10.6B10.2B8.27B12.4B12.4B5.30B4.92B4.94B4.32B4.13B
Gross profit48.1B43.9B37.5B32.0B25.0B21.3B19.5B17.2B18.1B18.9B
Research and development14.2B13.6B10.9B9.76B9.74B5.99B6.06B5.93B5.76B5.89B
Selling, general and administrative19.9B20.0B19.2B18.4B15.2B11.3B11.7B10.0B10.2B9.41B
Operating income13.7B10.0B8.19B3.76B1.06B5.16B2.92B3.39B3.68B4.90B
Depreciation and amortization5.73B5.07B5.39B5.48B6.53B3.15B3.76B2.74B2.47B2.36B
EBITDA19.5B15.1B13.6B9.24B7.59B8.31B6.69B6.13B6.14B7.26B
Interest expense1.69B1.74B1.63B1.35B1.30B1.31B1.43B1.42B1.51B1.38B
Income before tax12.4B8.69B6.90B2.50B-265.0M3.92B1.55B1.99B2.23B3.55B
Income tax2.17B1.65B938.0M-792.0M-380.0M772.0M321.0M-57.0M-641.0M146.0M
Net income10.2B7.04B5.96B3.29B112.0M3.20B1.33B2.15B3.00B3.50B
Earnings per share, basic6.604.543.842.120.082.441.031.702.372.77
Earnings per share, diluted6.544.503.812.110.082.441.031.702.372.76

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents5.71B5.49B5.84B6.17B6.33B7.83B5.37B4.83B3.32B5.02B
Short-term investments30.0M166.0M122.0M239.0M69.0M160.0M849.0M849.0M1.23B884.0M
Receivables15.2B13.0B12.1B10.5B9.64B7.02B5.76B5.57B5.01B4.57B
Inventory6.56B5.29B5.42B4.70B8.98B4.02B3.19B2.89B3.04B2.33B
Current assets28.7B25.8B25.1B22.6B26.2B19.5B15.6B15.6B13.2B13.3B
Property, plant and equipment13.0B10.3B9.40B8.51B9.18B8.25B7.69B7.42B7.62B6.85B
Goodwill21.2B21.0B20.0B19.8B20.0B11.8B11.7B11.7B11.8B11.7B
Total assets114.1B104.0B101.1B96.5B105.4B66.7B61.4B60.7B63.4B62.5B
Accounts payable25.3B22.5B22.4B19.0B18.9B15.8B14.0B12.8B11.6B10.5B
Current liabilities30.6B27.9B30.5B26.3B22.6B20.3B18.1B16.3B16.4B15.3B
Long-term debt24.7B26.5B22.4B23.0B28.1B17.5B15.7B17.4B15.6B14.5B
Total debt29.6B30.3B28.6B29.2B30.8B20.4B18.2B19.1B17.8B16.8B
Total liabilities65.4B63.2B62.0B59.4B66.1B51.1B46.8B46.6B46.7B45.9B
Shareholders' equity48.7B40.8B39.1B37.0B39.3B15.6B13.1B12.5B15.0B14.9B
Shares outstanding1.56B1.56B1.56B1.56B1.43B1.31B1.30B1.27B1.27B1.27B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations14.6B11.9B10.3B9.81B5.96B4.80B2.97B2.62B3.58B4.14B
Capital spending-2.81B-1.92B-1.36B-1.09B-1.09B-961.0M-979.0M-1.04B-1.33B-1.45B
Free cash flow11.8B9.94B8.98B8.72B4.87B3.84B1.99B1.57B2.25B2.70B
Cash from investing-6.81B-7.98B-4.06B-2.96B-11.1B-285.0M-657.0M963.0M-2.33B-3.97B
Cash from financing-7.54B-4.00B-6.57B-6.82B3.65B-2.20B-1.76B-2.04B-2.94B-1.32B
Dividends paid-4.97B-4.63B-4.48B-4.36B-3.86B-3.57B-3.59B-3.48B-3.52B-3.56B
Share buybacks-521.0M-81.0M3.71B-920.0M-149.0M3.05B314.0M2.97B2.31B2.78B
Change in cash223.0M-115.0M-286.0M25.0M-1.45B2.31B547.0M1.54B-1.69B-1.15B

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 16, 2026Current reportSEC
6-K · Report of a foreign issuerNov 16, 2026Current reportSEC
6-K · Report of a foreign issuerNov 16, 2026Current reportSEC
6-K · Report of a foreign issuerNov 16, 2026Current reportSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
6-K · Report of a foreign issuerNov 2, 2026Current reportSEC
6-K · Report of a foreign issuerNov 2, 2026Current reportSEC
6-K · Report of a foreign issuerOct 30, 2026Current reportSEC
3rd Quarter ResultsOct 30, 2026Other filingsLondon Stock Exchange
6-K · Report of a foreign issuerOct 27, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerOct 22, 2026Current reportSEC
4 · Change in ownershipOct 8, 2026Insider tradeSEC
6-K · Report of a foreign issuerOct 5, 2026Current reportSEC
6-K · Report of a foreign issuerOct 2, 2026Current reportSEC
6-K · Report of a foreign issuerOct 1, 2026Current reportSEC
6-K · Report of a foreign issuerOct 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 29, 2026Current reportSEC
6-K · Report of a foreign issuerSep 23, 2026Current reportSEC
6-K · Report of a foreign issuerSep 21, 2026Current reportSEC
6-K · Report of a foreign issuerSep 21, 2026Current reportSEC
6-K · Report of a foreign issuerSep 18, 2026Current reportSEC
6-K · Report of a foreign issuerSep 15, 2026Current reportSEC
6-K · Report of a foreign issuerSep 15, 2026Current reportSEC
6-K · Report of a foreign issuerSep 14, 2026Current reportSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
6-K · Report of a foreign issuerSep 8, 2026Current reportSEC
6-K · Report of a foreign issuerSep 8, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
6-K · Report of a foreign issuerAug 27, 2026Current reportSEC
6-K · Report of a foreign issuerAug 25, 2026Current reportSEC
6-K · Report of a foreign issuerAug 19, 2026Current reportSEC
6-K · Report of a foreign issuerAug 17, 2026Current reportSEC
6-K · Report of a foreign issuerAug 17, 2026Current reportSEC
6-K · Report of a foreign issuerAug 17, 2026Current reportSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
6-K · Report of a foreign issuerAug 3, 2026Current reportSEC
6-K · Report of a foreign issuerAug 3, 2026Current reportSEC
6-K · Report of a foreign issuerJul 31, 2026Current reportSEC
6-K · Report of a foreign issuerJul 27, 2026Current reportSEC
6-K · Report of a foreign issuerJul 27, 2026Current reportSEC
6-K · Report of a foreign issuerJul 27, 2026Current reportSEC
Half-year Financial ReportJul 27, 2026Interim reportLondon Stock Exchange
6-K · Report of a foreign issuerJul 23, 2026Current reportSEC
6-K · Report of a foreign issuerJul 14, 2026Current reportSEC
6-K · Report of a foreign issuerJul 9, 2026Current reportSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
6-K · Report of a foreign issuerJul 1, 2026Current reportSEC
6-K · Report of a foreign issuerJul 1, 2026Current reportSEC
11-K · Annual report of an employee planJun 29, 2026Annual reportSEC
6-K · Report of a foreign issuerJun 29, 2026Current reportSEC
6-K · Report of a foreign issuerJun 29, 2026Current reportSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
6-K · Report of a foreign issuerJun 15, 2026Current reportSEC
6-K · Report of a foreign issuerJun 1, 2026Current reportSEC
6-K · Report of a foreign issuerJun 1, 2026Current reportSEC
6-K · Report of a foreign issuerMay 29, 2026Current reportSEC
25-NSEMay 28, 2026Other filingsSEC
6-K · Report of a foreign issuerMay 27, 2026Current reportSEC
6-K · Report of a foreign issuerMay 26, 2026Current reportSEC
6-K · Report of a foreign issuerMay 26, 2026Current reportSEC
6-K · Report of a foreign issuerMay 26, 2026Current reportSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
6-K · Report of a foreign issuerMay 18, 2026Current reportSEC
6-K · Report of a foreign issuerMay 18, 2026Current reportSEC
6-K · Report of a foreign issuerMay 18, 2026Current reportSEC
6-K · Report of a foreign issuerMay 14, 2026Current reportSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
6-K · Report of a foreign issuerMay 1, 2026Current reportSEC
6-K · Report of a foreign issuerMay 1, 2026Current reportSEC
6-K · Report of a foreign issuerMay 1, 2026Current reportSEC
6-K · Report of a foreign issuerApr 29, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeApr 28, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerApr 28, 2026Current reportSEC
6-K · Report of a foreign issuerApr 27, 2026Current reportSEC
6-K · Report of a foreign issuerApr 23, 2026Current reportSEC
6-K · Report of a foreign issuerApr 21, 2026Current reportSEC
6-K · Report of a foreign issuerApr 20, 2026Current reportSEC
6-K · Report of a foreign issuerApr 9, 2026Current reportSEC
25-NSEApr 8, 2026Other filingsSEC
6-K · Report of a foreign issuerApr 2, 2026Current reportSEC
6-K · Report of a foreign issuerApr 1, 2026Current reportSEC
6-K · Report of a foreign issuerMar 31, 2026Current reportSEC
6-K · Report of a foreign issuerMar 27, 2026Current reportSEC
6-K · Report of a foreign issuerMar 20, 2026Current reportSEC
3 · Initial statement of ownershipMar 19, 2026Insider tradeSEC
6-K · Report of a foreign issuerMar 16, 2026Current reportSEC
6-K · Report of a foreign issuerMar 10, 2026Current reportSEC
6-K · Report of a foreign issuerMar 10, 2026Current reportSEC
6-K · Report of a foreign issuerMar 6, 2026Current reportSEC
6-K · Report of a foreign issuerMar 6, 2026Current reportSEC
6-K · Report of a foreign issuerMar 6, 2026Current reportSEC
CERT · Exchange's certificate of listingMar 4, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeMar 3, 2026Other filingsSEC
6-K · Report of a foreign issuerMar 2, 2026Current reportSEC
6-K · Report of a foreign issuerMar 2, 2026Current reportSEC
424B2 · ProspectusFeb 27, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 26, 2026Current reportSEC
FWP · Free writing prospectusFeb 25, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 25, 2026Current reportSEC
424B2 · ProspectusFeb 25, 2026Offer documentSEC
IRANNOTICEFeb 24, 2026Other filingsSEC
20-F · Annual reportFeb 24, 2026Annual reportSEC
6-K · Report of a foreign issuerFeb 24, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 24, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 24, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 20, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 10, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansFeb 3, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 3, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 2, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 2, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 2, 2026Current reportSEC
25Jan 30, 2026Other filingsSEC
6-K · Report of a foreign issuerJan 30, 2026Current reportSEC
6-K · Report of a foreign issuerJan 29, 2026Current reportSEC
CERT · Exchange's certificate of listingJan 22, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeJan 22, 2026Other filingsSEC
CERT · Exchange's certificate of listingJan 22, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeJan 22, 2026Other filingsSEC
6-K · Report of a foreign issuerJan 20, 2026Current reportSEC
6-K · Report of a foreign issuerJan 8, 2026Current reportSEC
6-K · Report of a foreign issuerJan 2, 2026Current reportSEC
6-K · Report of a foreign issuerDec 22, 2025Current reportSEC
6-K · Report of a foreign issuerDec 22, 2025Current reportSEC
6-K · Report of a foreign issuerDec 22, 2025Current reportSEC
6-K · Report of a foreign issuerDec 19, 2025Current reportSEC
6-K · Report of a foreign issuerDec 16, 2025Current reportSEC
6-K · Report of a foreign issuerDec 16, 2025Current reportSEC
6-K · Report of a foreign issuerDec 4, 2025Current reportSEC
6-K · Report of a foreign issuerDec 1, 2025Current reportSEC
6-K · Report of a foreign issuerDec 1, 2025Current reportSEC
6-K · Report of a foreign issuerNov 26, 2025Current reportSEC
6-K · Report of a foreign issuerNov 24, 2025Current reportSEC
6-K · Report of a foreign issuerNov 20, 2025Current reportSEC
6-K · Report of a foreign issuerNov 17, 2025Current reportSEC
25-NSENov 14, 2025Other filingsSEC
6-K · Report of a foreign issuerNov 14, 2025Current reportSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
6-K · Report of a foreign issuerNov 10, 2025Current reportSEC
6-K · Report of a foreign issuerNov 6, 2025Current reportSEC
6-K · Report of a foreign issuerNov 3, 2025Current reportSEC
6-K · Report of a foreign issuerNov 3, 2025Current reportSEC
6-K · Report of a foreign issuerNov 3, 2025Current reportSEC
6-K · Report of a foreign issuerOct 28, 2025Current reportSEC
6-K · Report of a foreign issuerOct 28, 2025Current reportSEC
6-K · Report of a foreign issuerOct 22, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 14, 2025Current reportSEC
6-K · Report of a foreign issuerOct 7, 2025Current reportSEC
6-K · Report of a foreign issuerOct 6, 2025Current reportSEC
6-K · Report of a foreign issuerOct 1, 2025Current reportSEC
6-K · Report of a foreign issuerSep 29, 2025Current reportSEC
6-K · Report of a foreign issuerSep 29, 2025Current reportSEC
6-K · Report of a foreign issuerSep 29, 2025Current reportSEC
6-K · Report of a foreign issuerSep 25, 2025Current reportSEC
6-K · Report of a foreign issuerSep 22, 2025Current reportSEC
6-K · Report of a foreign issuerSep 22, 2025Current reportSEC
6-K · Report of a foreign issuerSep 17, 2025Current reportSEC
6-K · Report of a foreign issuerSep 17, 2025Current reportSEC
6-K · Report of a foreign issuerSep 2, 2025Current reportSEC
6-K · Report of a foreign issuerAug 28, 2025Current reportSEC
6-K · Report of a foreign issuerAug 26, 2025Current reportSEC
6-K · Report of a foreign issuerAug 21, 2025Current reportSEC
6-K · Report of a foreign issuerAug 18, 2025Current reportSEC
6-K · Report of a foreign issuerAug 15, 2025Current reportSEC
6-K · Report of a foreign issuerAug 12, 2025Current reportSEC
6-K · Report of a foreign issuerAug 1, 2025Current reportSEC
6-K · Report of a foreign issuerJul 29, 2025Current reportSEC
6-K · Report of a foreign issuerJul 24, 2025Current reportSEC
6-K · Report of a foreign issuerJul 22, 2025Current reportSEC
6-K · Report of a foreign issuerJul 16, 2025Current reportSEC
6-K · Report of a foreign issuerJul 14, 2025Current reportSEC
6-K · Report of a foreign issuerJul 7, 2025Current reportSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
11-K · Annual report of an employee planJun 26, 2025Annual reportSEC
6-K · Report of a foreign issuerJun 24, 2025Current reportSEC
6-K · Report of a foreign issuerJun 13, 2025Current reportSEC
6-K · Report of a foreign issuerJun 12, 2025Current reportSEC
6-K · Report of a foreign issuerJun 6, 2025Current reportSEC
6-K · Report of a foreign issuerJun 2, 2025Current reportSEC
6-K · Report of a foreign issuerJun 2, 2025Current reportSEC
6-K · Report of a foreign issuerMay 27, 2025Current reportSEC
6-K · Report of a foreign issuerMay 23, 2025Current reportSEC
6-K · Report of a foreign issuerMay 21, 2025Current reportSEC
6-K · Report of a foreign issuerMay 20, 2025Current reportSEC
6-K · Report of a foreign issuerMay 9, 2025Current reportSEC
6-K · Report of a foreign issuerMay 7, 2025Current reportSEC
6-K · Report of a foreign issuerMay 6, 2025Current reportSEC
6-K · Report of a foreign issuerMay 2, 2025Current reportSEC
6-K · Report of a foreign issuerMay 1, 2025Current reportSEC
6-K · Report of a foreign issuerMay 1, 2025Current reportSEC

This page holds 200 of 1,003 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from AstraZeneca PLC’s releases · as of Feb 26, 2026

Common shares
1,550,917,690
Fully diluted
1,550,917,690

Fully diluted

LineShares
Common shares1,550,917,690

Share count over time

CountShares
Nov 22, 20261,550,917,690

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Mediolanum International Funds Ltd183KUS$30.1MSep 30, 2026
Loftus Peak Pty Ltd103KUS$16.6MSep 30, 2026
Mengis Capital Management, Inc.48,578US$7.84MSep 30, 2026
Stanley-Laman Group, Ltd.23,076US$3.73MSep 30, 2026
Raelipskie Partnership8,212US$1.55MSep 30, 2026
Westport Asset Management Inc7,500US$1.21MSep 30, 2026
A. D. Beadell Investment Counsel, Inc.6,968US$1.13MSep 30, 2026
Harvest Fund Management Co., Ltd5,158US$834KSep 30, 2026
Cullinan Associates Inc3,638US$587KSep 30, 2026
Fruth Investment Management3,499US$564KSep 30, 2026
All 22 holders
HolderSharesValueAs of
Philadelphia Trust Co1,843US$298KSep 30, 2026
Geneos Wealth Management Inc.1,245US$201KSep 30, 2026
Asset Planning,Inc500US$80,735Sep 30, 2026
Burkett Financial Services, LLC403US$65,072Sep 30, 2026
Pinnacle Holdings, LLC400US$64,588Sep 30, 2026
Compass Financial Management LLC305US$49,248Sep 30, 2026
Markowski Investments264US$42,628Sep 30, 2026
Ogorek Anthony Joseph /NY/208US$33,000Sep 30, 2026
KERR FINANCIAL PLANNING Corp110US$17,762Sep 30, 2026
Byrne Asset Management LLC72US$11,354Sep 30, 2026
Winch Advisory Services, LLC21US$3,413Sep 30, 2026
Lam Group, Inc.1US$161Sep 30, 2026

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund22MUS$3.75BJul 31, 2026
New Perspective Fund16.8MUS$3.16BJun 30, 2026
Vanguard Developed Markets Index Fund14.7MUS$2.74BJun 30, 2026
Vanguard Primecap Fund11.9MUS$2.26BJun 30, 2026
iShares Core MSCI EAFE ETF11.2MUS$1.91BJul 31, 2026
Vanguard Health Care Fund10.3MUS$1.75BJul 31, 2026
EUPAC Fund9.86MUS$1.85BJun 30, 2026
Goldman Sachs GQG Partners International Opportunities Fund8.96MUS$1.52BJul 31, 2026
Capital Income Builder8.39MUS$1.43BJul 31, 2026
Fidelity International Index Fund5.83MUS$1.08BMay 31, 2026
Show 50 holders
HolderSharesValueAs of
iShares MSCI EAFE ETF5.34MUS$909MJul 31, 2026
Income Fund of America4.54MUS$773MJul 31, 2026
Vanguard European Stock Index Fund3.59MUS$611MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund3.57MUS$608MJul 31, 2026
MFS International Growth Fund3.46MUS$643MMay 31, 2026
Schwab International Equity ETF3.34MUS$621MMay 31, 2026
Putnam Large Cap Value Fund3.14MUS$532MJul 31, 2026
Causeway International Value Fund3.11MUS$581MJun 30, 2026
American Balanced Fund3.05MUS$571MJun 30, 2026
Fidelity Series Global ex U.S. Index Fund3.01MUS$512MJul 31, 2026
Washington Mutual Investors Fund2.89MUS$490MJul 31, 2026
T. Rowe Price Overseas Stock Fund2.61MUS$443MJul 31, 2026
Strategic Advisers Fidelity International Fund2.55MUS$475MMay 31, 2026
Vanguard Equity Income Fund2.47MUS$468MJun 30, 2026
Nuveen International Equity Index Fund2.45MUS$416MJul 31, 2026
WCM Focused International Growth Fund2.43MUS$453MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account2.41MUS$451MJun 30, 2026
Vanguard Primecap Core Fund2.38MUS$451MJun 30, 2026
Columbia Dividend Income Fund2.33MUS$432MMay 31, 2026
iShares MSCI EAFE Growth ETF2.33MUS$396MJul 31, 2026
Capital World Growth & Income Fund2.3MUS$428MMay 31, 2026
American Funds Fundamental Investors2.28MUS$427MJun 30, 2026
Vanguard International Growth Fund2.11MUS$391MMay 31, 2026
iShares Core MSCI Total International Stock ETF2.08MUS$353MJul 31, 2026
International Growth and Income Fund1.98MUS$370MJun 30, 2026
Fidelity Series Overseas Fund1.94MUS$331MJul 31, 2026
Vanguard Wellington Fund1.9MUS$352MMay 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF1.87MUS$349MJun 30, 2026
American Funds Global Insight Fund1.76MUS$299MJul 31, 2026
T. Rowe Price International Value Equity Fund1.73MUS$295MJul 31, 2026
MFS Research International Fund1.7MUS$316MMay 31, 2026
Six Circles International Unconstrained Equity Fund1.69MUS$316MJun 30, 2026
iShares MSCI United Kingdom ETF1.67MUS$310MMay 31, 2026
iShares Core MSCI International Developed Markets ETF1.64MUS$279MJul 31, 2026
T. Rowe Price International Stock Fund1.61MUS$274MJul 31, 2026
Thornburg Investment Income Builder Fund1.55MUS$289MJun 30, 2026
T. Rowe Price Dividend Growth Fund, Inc.1.49MUS$282MJun 30, 2026
The Hartford Dividend And Growth Fund1.46MUS$247MJul 31, 2026
Strategic Advisers International Fund1.4MUS$261MMay 31, 2026
New World Fund Inc1.37MUS$233MJul 31, 2026

This page holds 50 of 940 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Pascal Soriot
Chief Executive Officer (CEO)/Managing Directory
Buy60,000GBP 121.02GBP 7.26MSep 14, 2026
Aradhana Sarin
Chief Financial Officer (CFO)
Buy73GBP 0.00Sep 14, 2026
Michel Demare
Chairman of the Board of Directors
Buy2,500GBP 121.21GBP 303KSep 14, 2026
Aradhana Sarin
Chief Financial Officer (CFO)
Buy11,133GBP 0.00Aug 17, 2026
Sharma Mani
Officer: See Remarks
Buy20USD 160.57US$3,248Aug 8, 2026
Sharma Mani
Officer: See Remarks
Sale11,893USD 185.78US$2.21MMay 20, 2026
Pascal Soriot
Chief Executive Officer (CEO)/Managing Directory
Buy18,359GBP 0.00May 14, 2026
Pascal Soriot
Chief Executive Officer (CEO)/Managing Directory
Buy101,495GBP 0.00Mar 5, 2026
Aradhana Sarin
Chief Financial Officer (CFO)
Buy4,863GBP 0.00Mar 4, 2026
Pascal Soriot
Chief Executive Officer (CEO)/Managing Directory
Buy14,967GBP 0.00Mar 4, 2026
All 11 trades
TradeTradeSharesPriceValueDate
Nazneen Rahman
Member of the Board of Directors
Sale297GBP 134.96GBP 40,083Dec 18, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Euan Ashley
Other companies: DexCom, Inc. (Director · Since at least Oct 24, 2025)
Non-Executive Director · Since at least Nov 5, 2026
Anna ManzNon-Executive Director · Since at least Nov 5, 2026
Aradhana SarinExecutive Director and CFO · Since at least Nov 5, 2026
Birgit ConixNon-Executive Director · Since at least Nov 5, 2026
David FredricksonExecutive Vice-President, Oncology Business Unit · Since at least Nov 4, 2026
Diana LayfieldNon-Executive Director · Since at least Nov 5, 2026
Iskra ReicExecutive Vice-President, International · Since at least Jul 27, 2026
Jeff PottChief Human Resources Officer, Chief Compliance Officer and General Counsel · Since at least Nov 4, 2026
Karen KnudsenNon-Executive Director · Since at least Nov 5, 2026
Mani SharmaSee remarks · Since at least Mar 18, 2026
All 22 people
PersonSeat
Marc DunoyerChief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca · Since at least Oct 22, 2026
Marcus WallenbergNon-Executive Director · Since at least Nov 5, 2026
Maria BelvisiChief Scientific Officer · Apr 10, 2026 – Nov 5, 2026 · Past
Michel DemaréNon-Executive Chair of the Board · Since at least Jul 27, 2026
Pam ChengExecutive Vice President, Global Operations, IT & Chief Sustainability Officer · Since at least Oct 30, 2026
Pascal SoriotExecutive Director and CEO · Since at least Oct 30, 2026
Ruud DobberExecutive Vice-President, BioPharmaceuticals Business Unit · Since at least Sep 23, 2026
Sharon BarrExecutive Vice-President, BioPharmaceuticals R&D · Since at least Sep 8, 2026
Sheri McCoyNon-Executive Director · Since at least Nov 5, 2026
Susan GalbraithExecutive Vice-President, Oncology R&D · Since at least Oct 25, 2026
Tony MokNon-Executive Director · Since at least Nov 4, 2026
Wan Ling MartelloNon-Executive Director · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about AstraZeneca PLC.